other:Article Title: KIF20A promotes cervical cancer progression by interacting with CLIP1.
Article Snippet: Materials The following antibodies were utilized in the experiments: anti-KIF20A (Proteintech, 15911-1-AP, 1:2000), anti-GAPDH (ZEN BIO, 200306-7E4, 1:10000), anti-CLIP1 (Proteintech, 23839-1-AP, 1:2000), anti-Rabbit IgG(H+L)HRP secondary antibody (Abclonal, AS014, 1:10000), and anti-Mouse IgG(H+L)HRP secondary antibody (Abclonal, AS003, 1:10000).
Article Title: Hypothermic oxygenated perfusion inhibits CLIP1-mediated TIRAP ubiquitination via TFPI2 to reduce ischemia‒reperfusion injury of the fatty liver.
Article Snippet: The primary antibodies used in this study were as follows: antiTFPI2 (1:4000, Abcam, ab186747, Cambridge, UK), anti-CLIP1 (1:1000, Proteintech, 23839-1-AP, Wuhan, China), anti-TIRAP (1:1000, Abcam, ab17218, Cambridge, UK), anti-IL-1β (1:5000, Proteintech, 16806-1-AP, Wuhan, China), anti-TNF-α (1:1000, Proteintech, 60291-1-Ig, Wuhan, China), anti-HMGB1 (1:3000, Proteintech, 10829-1-AP, Wuhan, China), anti-TLR4 (1:1000, Proteintech, 19811-1-AP, Wuhan, China), anti-p65 (1:3000, Proteintech, 10745-1-AP, Wuhan, China), anti-phospho-p65 (Ser536) (1:500, Affinity Biosciences, AF2006, Shanghai, China), anti-IκBα (1:5000, Proteintech, 10268-1-AP, Wuhan, China), anti-phospho-IκBα (Ser32/Ser36) (1:300, Affinity Biosciences, AF2002, Shanghai, China), anti-ubiquitin (1:300, Proteintech, 10201-2-AP, Wuhan, China), anti-His tag (1:5000, Proteintech, 66005-1-AP, Wuhan, China), anti-MYC tag (1:5000, Proteintech, 16286-1-AP, Wuhan, China), anti-HA tag (1:5000, Proteintech, 51064-2-AP, Wuhan, China), anti-Flag tag (1:20000, Proteintech, 20543-1-AP, Wuhan, China), anti-GST tag (1:2000, Proteintech, 10000-0-AP, Wuhan, China), and antiβ-actin (1:10,000, Abclonal, AC026, Wuhan, China).
Article Title: Hypothermic oxygenated perfusion inhibits CLIP1-mediated TIRAP ubiquitination via TFPI2 to reduce ischemia‒reperfusion injury of the fatty liver
Article Snippet: The primary antibodies used in this study were as follows: anti-TFPI2 (1:4000, Abcam, ab186747, Cambridge, UK), anti-CLIP1 (1:1000, Proteintech, 23839-1-AP, Wuhan, China), anti-TIRAP (1:1000, Abcam, ab17218, Cambridge, UK), anti-IL-1β (1:5000, Proteintech, 16806-1-AP, Wuhan, China), anti-TNF-α (1:1000, Proteintech, 60291-1-Ig, Wuhan, China), anti-HMGB1 (1:3000, Proteintech, 10829-1-AP, Wuhan, China), anti-TLR4 (1:1000, Proteintech, 19811-1-AP, Wuhan, China), anti-p65 (1:3000, Proteintech, 10745-1-AP, Wuhan, China), anti-phospho-p65 (Ser536) (1:500, Affinity Biosciences, AF2006, Shanghai, China), anti-IκBα (1:5000, Proteintech, 10268-1-AP, Wuhan, China), anti-phospho-IκBα (Ser32/Ser36) (1:300, Affinity Biosciences, AF2002, Shanghai, China), anti-ubiquitin (1:300, Proteintech, 10201-2-AP, Wuhan, China), anti-His tag (1:5000, Proteintech, 66005-1-AP, Wuhan, China), anti-MYC tag (1:5000, Proteintech, 16286-1-AP, Wuhan, China), anti-HA tag (1:5000, Proteintech, 51064-2-AP, Wuhan, China), anti-Flag tag (1:20000, Proteintech, 20543-1-AP, Wuhan, China), anti-GST tag (1:2000, Proteintech, 10000-0-AP, Wuhan, China), and anti-β-actin (1:10,000, Abclonal, AC026, Wuhan, China).
|